解读抗整体素α4β7维多利祖马布与细胞交叉匹配的干扰
Marine Cargou1, Julien Lion2, Intissar Dalhoumi1,3
1CHU de Bordeaux, Laboratoire D'immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
HLA
|June 27, 2025
概括
维多利祖马布 (VDZ) 可以干扰T细胞流动细胞计交叉匹配 (FCXM) 在有炎症性肠病 (IBD) 的器官移植受体中. 这种药物诱导的干扰可能会导致错误的T细胞FCXM结果,影响免疫风险评估.
科学领域:
- 移植免疫学 移植免疫学
- 药物诱导的免疫干扰 药物诱导的免疫干扰
- 流细胞测量应用程序的应用.
背景情况:
- 器官移植中的免疫风险评估依赖于细胞交叉匹配 (XM) 试验.
- 某些药物可以干扰XM结果,可能影响移植结果.
- 维多利祖马布 (VDZ) 是一种治疗炎症性肠病 (IBD) 的药物,其向免疫细胞上的整合素α4β7.
研究的目的:
- 调查vedolizumab (VDZ) 与器官移植受体细胞交叉匹配 (XM) 试验的潜在干扰.
- 确定VDZ是否影响流细胞计交叉匹配 (FCXM) 结果,特别是在捐赠体特异性抗体 (DSA) 的背景下.
主要方法:
- 来自两名接受脏和肝移植的接受者用VDZ治疗的血清的分析,使用Luminex测定和自动和合金流细胞计交叉匹配 (FCXM).
- 在VDZ治疗的不同阶段 (诱导和维护) 收集的测试血清,以评估干扰动力学.
- 使用Luminex查和单抗原测定来排除与虚拟XM和DSA检测的干扰.
主要成果:
- 所有通过Luminex测试测试的血清对捐赠者特异性抗体 (DSA) 呈阴性,表明没有干扰虚拟XM.
- 在VDZ维持疗法期间观察到T细胞上的IgG allo-FCXM阳性,比率是负对照的1.6-4.4倍.
- VDZ干扰特别影响了表达整合素α4β7的T细胞的一个子集,导致没有可检测的DSA的阳性T细胞FCXM.
结论:
- 维多利祖马布 (VDZ) 可能导致IBD的器官移植接受者错误阳性T细胞FCXM结果.
- 移植团队应考虑VDZ治疗作为意外阳性T细胞FCXM的潜在原因,特别是在IBD患者中.
- 普罗纳斯治疗有效地废除了VDZ干扰,这表明表面蛋白相互作用的作用.
关键词:
哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈流量细胞计交叉匹配 交叉匹配干扰干扰是干扰的实体器官移植移植 实体器官移植我已经看到了Vedolizumab.更多相关视频
04:15Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
2.0K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.4K
相关概念视频
Cross-reactivity
31.5K
Overview
31.5K
Immunoglobulin-like Cell Adhesion Molecules
3.4K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.4K
Integrins
4.2K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.2K
